{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T22:59:54Z","timestamp":1772578794767,"version":"3.50.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T00:00:00Z","timestamp":1459382400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s00520-016-3189-z","type":"journal-article","created":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T02:31:19Z","timestamp":1459391479000},"page":"3695-3703","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Health-related quality of life in patients with neuroendocrine tumors: an investigation of treatment type, disease status, and symptom burden"],"prefix":"10.1007","volume":"24","author":[{"given":"Timothy P.","family":"Pearman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer L.","family":"Beaumont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Cella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maureen P.","family":"Neary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,31]]},"reference":[{"issue":"18","key":"3189_CR1","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","volume":"26","author":"JC Yao","year":"2008","unstructured":"Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey J-N, Rashid A, Evans DB (2008) One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 26(18):3063\u20133072","journal-title":"J Clin Oncol"},{"issue":"1","key":"3189_CR2","first-page":"8","volume":"2","author":"RE Rossi","year":"2014","unstructured":"Rossi RE, Massironi S, Conte D, Peracchi M (2014) Therapy for metastatic pancreatic neuroendocrine tumors. Ann Transl Med 2(1):8","journal-title":"Ann Transl Med"},{"key":"3189_CR3","doi-asserted-by":"crossref","first-page":"765","DOI":"10.6004\/jnccn.2012.0076","volume":"10","author":"NB Jones","year":"2012","unstructured":"Jones NB, Shah MH, Bloomston M (2012) Liver-directed therapies in patients with advanced neuroendocrine tumors. J Natl Compr Cancer Netw 10:765\u2013774","journal-title":"J Natl Compr Cancer Netw"},{"issue":"6","key":"3189_CR4","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1177\/1756283X13498808","volume":"6","author":"J Sharma","year":"2013","unstructured":"Sharma J, Duque M, Saif MW (2013) Emerging therapies and latest development in the treatment of unresectable pancreatic neuroendocrine tumors: an update for clinicians. Therapeutic Advances in Gastroenterology. 6(6):474\u2013490","journal-title":"Therapeutic Advances in Gastroenterology."},{"issue":"18","key":"3189_CR5","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1016\/j.ejca.2014.10.001","volume":"50","author":"E Mitry","year":"2014","unstructured":"Mitry E, Walter T, Baudin E, Kurtz JE, Ruszniewski P, Dominguez-Tinajero S, Bengrine-Lefevre L, Cadiot G, Dromain C, Farace F, Rougier P, Ducreux M (2014) Bevacizumab plus capecitabine in patients with progressive advanced well-differentiated neuroendocrine tumors of the gastrointestinal (GI-NETS) tract (BETTER trial): a phase II non-randomised trial. Eur J Cancer 50(18):3107\u20133115","journal-title":"Eur J Cancer"},{"issue":"3","key":"3189_CR6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/MPA.0b013e3182328045","volume":"41","author":"JL Beaumont","year":"2012","unstructured":"Beaumont JL, Cella D, Phan AT, Choi S, Liu Z, Yao JC (2012) Comparison of health-related quality of life in patients with neuroendocrine tumors with quality of life in the general US population. Pancreas 41(3):461\u2013466","journal-title":"Pancreas"},{"issue":"3","key":"3189_CR7","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","volume":"11","author":"DF Cella","year":"1993","unstructured":"Cella DF, Tulsky DS, Gray G, Sarafian B, Lin E, Bonomi A, et al. (1993) The Functional Assessment of Cancer Therapy Scale: development and validation of the general measure. J Clin Oncol 11(3):570\u2013579","journal-title":"J Clin Oncol"},{"key":"3189_CR8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1477-7525-5-18","volume":"5","author":"C Frojd","year":"2007","unstructured":"Frojd C, Larsson G, Lampic C, von Essen L (2007) Health related quality of life and psychosocial function among patients with carcinoid tumours: a longitudinal prospective and comparative study. Health Qual Life Outcomes 5:18","journal-title":"Health Qual Life Outcomes"},{"issue":"7","key":"3189_CR9","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s11136-009-9496-9","volume":"18","author":"RD Hays","year":"2009","unstructured":"Hays RD, Bjorner J, Revicki RA, Spritzer KL, Cella D (2009) Development of physical and mental health summary scores from the Patient Reported Outcomes Measurement Information System (PROMIS) global items. Quality of Life Research. 18(7):873\u2013880","journal-title":"Quality of Life Research."},{"issue":"4","key":"3189_CR10","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ejca.2005.10.025","volume":"42","author":"AH Davies","year":"2006","unstructured":"Davies AH, Larsson G (2006) Ardill J et al Development of a disease-specific quality of life questionnaire module for patients with gastrointestinal neuroendocrine tumours. Eur J Cancer 42(4):477\u2013484","journal-title":"Eur J Cancer"},{"issue":"3","key":"3189_CR11","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1097\/MPA.0b013e31819b6441","volume":"38","author":"E Vinik","year":"2009","unstructured":"Vinik E, Carlton CA (2009) Silva MP et al Development of the Norfolk quality of life tool for assessing patients with neuroendocrine tumors. Pancreas 38(3):e87\u2013e95","journal-title":"Pancreas"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-016-3189-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-016-3189-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-016-3189-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T02:09:52Z","timestamp":1559095792000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-016-3189-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,31]]},"references-count":11,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["3189"],"URL":"https:\/\/doi.org\/10.1007\/s00520-016-3189-z","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,31]]}}}